Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Hairy Cell Leukemia · Recurrent Hairy Cell Leukemia Variant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Comprehensive Cancer Center, Duarte, California, United States
Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
Contact: Principal Investigator (Avyakta Kallam)
City of Hope at Irvine Lennar, Irvine, California, United States
Contact: Study coordinator (Site Public Contact) · 877-467-3411
Contact: Principal Investigator (Avyakta Kallam)
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States
Contact: Study coordinator (Site Public Contact) · 954-461-2180
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Doral, Doral, Florida, United States
Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States
Contact: Study coordinator (Site Public Contact) · 305-243-2647
Contact: Principal Investigator (Justin M. Watts)
University of Kansas Cancer Center, Kansas City, Kansas, United States
Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
Contact: Study coordinator (Site Public Contact) · 800-888-8823
Contact: Principal Investigator (Seung Tae Lee)
NCI - Center for Cancer Research, Bethesda, Maryland, United States
Contact: Study coordinator (Site Public Contact) · 800-411-1222
Contact: Principal Investigator (Robert J. Kreitman)
University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
Contact: Study coordinator (Site Public Contact) · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Kansas Cancer Center - North, Kansas City, Missouri, United States
Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
Contact: Principal Investigator (Joseph Bennett)
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States

Study leads

Robert J Kreitman
Principal Investigator
National Cancer Institute LAO

View source on ClinicalTrials.gov